L2 Asset Management’s Pfizer PFE Stock Holding History

L2 Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,099	Closed	-$380K	–	224
2023 Q3	$380K	Sell	1,099 -22,804	-95%	-$806K	0.18%	103
2023 Q2	$878K	Sell	23,903 -2,444	-9%	-$95.1K	0.43%	63
2023 Q1	$1.07M	Sell	26,347 -1,864	-7%	-$80.5K	0.59%	52
2022 Q4	$1.45M	Hold	28,211	–	–	0.9%	35
2022 Q3	$1.24M	Buy	28,211 +6,257	+29%	+$304K	0.85%	43
2022 Q2	$1.15M	Buy	21,954 +9,337	+74%	+$476K	0.84%	42
2022 Q1	$653K	Buy	12,617 +9,210	+270%	+$478K	0.38%	69
2021 Q4	$201K	Buy	+3,407	New	+$169K	0.14%	117
2020 Q2	–	Sell	-8,864	Closed	-$275K	–	75
2020 Q1	$275K	Sell	8,864 -16,253	-65%	-$554K	0.31%	62
2019 Q4	$934K	Buy	+25,117	New	+$895K	0.82%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

L2 Asset Management's PFE Position: Q4 2023 in Review

L2 Asset Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 1,099 shares — an estimated $380K sold.

L2 Asset Management first reported a position in PFE in Q4 2019 and held it in 10 quarters. The position peaked at $1.45M in Q4 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

L2 Asset Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
L2 Asset Management sold 1,099 Pfizer shares in Q4 2023, an estimated $380K.
L2 Asset Management first reported a position in Pfizer in Q4 2019 and held it in 10 quarters.
L2 Asset Management's Pfizer position peaked at $1.45M in Q4 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.